Skip to main content

Eli Lilly news in 2026: 30 dated events

The latest Eli Lilly event on this page is dated Nov 16, 2026. globenewswire.com reported: Stipple Bio Announces Multi-Target Multi-Modality Oncology Research Collaboration with Lilly.

Public (LLY)Pharmaceutical Manufacturing10,000+ employeeslilly.comLinkedIn

Get Eli Lilly's live signals in Claude or ChatGPT, or by API

AskWhat changed at Eli Lilly this week? Use Autobound signals for lilly.com.
Dated events
30
Last 90 days
30
Latest
Nov 16, 2026

Source: Autobound Signal API · 114 signals tracked for Eli Lilly · updated

News · latest 10

Latest Eli Lilly news

  1. Investment
  2. Acquisition
  3. Investment
  4. In development
    New Phase 3b data on Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together showed improved and durable efficacy, patient-reported and metabolic outcomes at one...Eli Lilly announced detailed 52-week results from its Phase 3b TOGETHER-PsA clinical trial evaluating the concomitant use of Taltz and Zepbound.
  5. In development
    Lilly's Foundayo (orforglipron) significantly reduced obstructive sleep apnea severity, reinforcing its potential to improve health beyond weight lossEli Lilly and Company announced positive Phase 3 clinical trial results for Foundayo (orforglipron) for the treatment of moderate-to-severe obstructive sleep apnea.
  6. Partnership
  7. Partnership
  8. Earnings
  9. In development
    After obesity, Eli Lilly is set for a big neurosciences pushEli Lilly is developing remternetug, a phase III investigational amyloid-targeting therapy for subcutaneous delivery to treat Alzheimer's disease.
  10. In development
    Lilly's retatrutide delivered greater A1C reduction and more than double the weight loss of Ozempic's highest approved dose in head-to-head trialEli Lilly and Company announced positive topline results from the Phase 3 TRANSCEND-T2D-2 clinical trial evaluating retatrutide in adults with type 2 diabetes.

Showing 10 of 30 dated events. The Signal API returns all of them.

Get them with one API call

Signal API · MCP

Track Eli Lilly with the Signal API

One POST /v1/companies/enrich call with lilly.com returns Eli Lilly news signals (news), each with its source. Or ask Claude through MCP.

2 credits per signal returned; zero-result calls are free. Endpoint reference

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"lilly.com","signal_types":["news"],"limit":20}'

Bulk data

Need this signal for 10,000+ companies?

Get a free sample file or a bulk feed (API, GCS push, flat file). The sample is real News records, as a CSV.

Talk to sales

Same industry

Questions about Eli Lilly news

What is the latest news on Eli Lilly?
The newest event on this page is dated Nov 16, 2026. globenewswire.com reported: Stipple Bio Announces Multi-Target Multi-Modality Oncology Research Collaboration with Lilly. This page lists 30 dated events for Eli Lilly, each with a source link.
What is going on with Eli Lilly?
The 10 latest events on this page cover investment (2), acquisition (1), in development (4), partnership (2) and earnings (1). The newest: Nov 16, 2026: Stipple Bio Announces Multi-Target Multi-Modality Oncology Research Collaboration with Lilly (globenewswire.com).

Page updated , the date of the newest row on this page.

Source. News articles about the company, one source link per event.

Method. Stories about the same event within 14 days merge into one row. Noise (lists, stock tips, recaps) is removed.

Data as of .

How this data is built →Get it from the Signal API →